Day: April 19, 2018 (Page 2)

On:

Here at Cannabis Now, every day is 420, so we’ve compiled a list of pro tips to help you live your 420 to the fullest on the biggest legal celebration of the holiday ever! Smoking large of boutique-quality cannabis can be a challenge, but thanks to all the new regulatedContinue Reading

On:

In a move that highlights the power of local governments over the California marijuana industry, the San Bernardino City Council shot down the planned 4/20-centric High Times Cannabis Cup by refusing to license this weekend’s event. The council vote, held less than two days before the biggest cannabis holiday of the year,Continue Reading

On:

British drugmaker GW Pharmaceuticals is seeking permission to sell its purified form of CBD as a medication for seizures in children. The post Cannabis-Based Drug Gets Positive Review From US Agency appeared first on Leafly. Read More: Cannabis-Based Drug Gets Positive Review From US AgencyContinue Reading

On:

Dr. Dabber, one of the nation’s leading concentrate technology companies, is entering the tabletop market with their new SWITCH to celebrate the biggest 420 ever. The folks at Dr. Dabber believe their new dual-purpose SWITCH is the most innovative cannabis device released in the 21st century, and it certainly hadContinue Reading

On:

Even though the iconic singer Sting — front man of the Police — professes to not be a huge consumer of cannabis (“[I] rarely smoke it socially,” he has said), it’s hard to imagine he wasn’t totally blitzed out of his mind when he signed up for this bizarre andContinue Reading

On:

A Toronto-based marijuana company focused on U.S. recreational and medical cannabis markets plans to spend about 23 million Canadian dollars ($18.3 million) in cash, stock and warrants to acquire a small licensed producer in Ontario. MPX Bioceutical agreed to acquire Peterborough-based Canveda for CA$3 million in cash, CA$15 million in stockContinue Reading

On:

A CBD treatment for epilepsy is closer to becoming the first cannabis medicine approved for the U.S. market. A panel of government health advisers gave a unanimous recommendation Thursday to the U.S. Food and Drug Administration to approve Epidiolex, a CBD medicine for rare epilepsy conditions that don’t respond toContinue Reading